Medstone Lithotripter Approval For Gallstone Use Expands Market By 7 Mil.
This article was originally published in The Gray Sheet
Executive Summary
FDA approval of Medstone International's STS extracorporeal shockwave lithotripter for use in treatment of gallstones, announced Sept. 6, increases the product's market potential by an additional 7 mil. patients, the firm estimates.